Circulating irisin in relation to insulin resistance and the metabolic syndrome
Park, K. H. et al. Circulating irisin in relation to insulin resistance and the metabolic syndrome. J. Clin. Endocrinol. Metab. http://dx.doi.org/10. 1210/jc.2013-2373.
Irisin mRNA and circulating levels in relation to other myokines in healthy and morbidly obese humans
Vamvini, M. T. et al. Irisin mRNA and circulating levels in relation to other myokines in healthy and morbidly obese humans. Eur. J. Endocrinol. 169, 829-834 (2013).
FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. MRNA expression and circulating concentrations in response to weight loss and exercise
Huh, J. Y. et al. FNDC5 and irisin in humans: I. Predictors of circulating concentrations in serum and plasma and II. mRNA expression and circulating concentrations in response to weight loss and exercise. Metabolism 61, 1725-1738 (2012).
Identification of evolutionarily conserved nonAUGinitiated N-terminal extensions in human coding sequences
Ivanov, I. P., Firth, A. E., Michel, A. M., Atkins, J. F. & Baranov, P. V. Identification of evolutionarily conserved nonAUGinitiated N-terminal extensions in human coding sequences. Nucleic Acids Res. 39, 4220-4234 (2011).
Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance
Moreno-Navarrete, J. M. Irisin is expressed and produced by human muscle and adipose tissue in association with obesity and insulin resistance. J. Clin. Endocrinol. Metab. 98, E769-E778 (2013).